Status:
COMPLETED
A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis
Lead Sponsor:
George Washington University
Conditions:
Psoriasis
Nonalcoholic Fatty Liver Disease
Eligibility:
All Genders
18-80 years
Brief Summary
Main objectives 1\. Establish the association of psoriasis and the presence of NAFLD in the patients with psoriasis attending dermatologic clinic center. Secondary objective 1. Evaluate for the pre...
Detailed Description
Psoriasis is a common inflammatory disorder of the skin and in some patients the joints. Several reports have demonstrated a possible association between psoriasis and diabetes mellitus, obesity, hype...
Eligibility Criteria
Inclusion
- Adults of both sexes from dermatologic or radiologic clinics, between the age 18 and 80 years who wish to voluntarily participate in the study and who have signed a written informed consent form to participate.
Exclusion
- Alcohol intake \> 30 g/day in males and \> 20 g/day in females.
- Presence of chronic liver disease.
- Presence of the hepatitis B virus surface antigen or the presence of virus hepatitis C antibodies.
- History of methotrexate, systemic corticosteroid, amiodarone, tamoxifen, estrogens, and/or nifedipine.
- Pregnancy
- Subjects with conditions or diseases hindering data collection and follow up of the study such as incapacitating diseases, cognitive deterioration, institutionalized patients.
Key Trial Info
Start Date :
November 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2016
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00930384
Start Date
November 1 2009
End Date
April 1 2016
Last Update
June 16 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
George Washington University Department of Dermatology
Washington D.C., District of Columbia, United States, 20037